BLUCEQUI
LIVE

Serial Number

79286221

Owner

SANDOZ AG

Filing Date

Apr 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BLUCEQUI Trademark

Serial Number: 79286221 • Registration: 6182298

BLUCEQUI is a trademark filed by SANDOZ AG on April 24, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SANDOZ AG (208 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 24, 2020

Registration Date

October 27, 2020

Published for Opposition

August 11, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 28, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Jan 3, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 13, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 26, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2020 R.PR
PUBLISHED FOR OPPOSITION
Aug 11, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Aug 7, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 22, 2020 OP2R
NOTICE OF PUBLICATION
Jul 22, 2020 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2020 CNSA
ASSIGNED TO EXAMINER
Jul 5, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 9, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 2, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 28, 2020 REPR